Medtronic plc (NYSE: MDT), a global healthcare technology leader, announces its intent to acquire SPR Therapeutics, Inc. (SPR), a privately held medical technology company and a recognized leader in temporary, percutaneous peripheral nerve stimulation (PNS) therapies for chronic pain management. The transaction consists of an upfront cash payment of approximately $650 million for all the outstanding equity in SPR. The acquisition continues Medtronic’s momentum in driving strategic deals that further build out the company’s core franchises.
Read the full article: Medtronic Announces Intent to Acquire SPR Therapeutics, Inc., Expanding Care Options for People Living with Chronic Pain //
Source: https://www.prnewswire.com/news-releases/medtronic-announces-intent-to-acquire-spr-therapeutics-inc-expanding-care-options-for-people-living-with-chronic-pain-302777023.html